Akebia director granted RSUs and stock options
Akebia Therapeutics, Inc. director Adrian Adams reported awards of equity-based compensation.
Rhea-AI Filing Summary
Akebia Therapeutics, Inc. director Adrian Adams reported awards of equity-based compensation. He received 35,700 shares of common stock as restricted stock units that were granted at no cash price and increase his direct holdings to 236,200 common shares after the award.
Adams was also granted a stock option for 53,600 shares of common stock with an exercise price of $1.02 per share, expiring on June 17, 2036. Both the restricted stock units and the stock option are scheduled to vest in full on the first anniversary of the grant date, or earlier immediately before the first annual stockholder meeting after the grant, subject to his continuous service to the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 89,300 shares
Grant/Award
2 txns
Insider
ADAMS ADRIAN
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 53,600 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 35,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 53,600 contracts (Direct);
Common Stock — 236,200 shares (Direct)
Footnotes (2)
- F1. The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
- F2. The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
RSU grant: 35,700 shares
Option grant size: 53,600 shares
Option exercise price: $1.02 per share
+2 more
5 metrics
RSU grant
35,700 shares
Restricted stock units granted to director on June 17, 2026
Option grant size
53,600 shares
Stock option covering common shares granted on June 17, 2026
Option exercise price
$1.02 per share
Conversion or exercise price for new stock option
Option expiration
June 17, 2036
Expiration date of stock option grant
Shares held after grant
236,200 shares
Common stock directly held by Adrian Adams after RSU grant
Key Terms
restricted stock units, 2023 Stock Incentive Plan, Non-Employee Director Compensation Program, Stock Option, +1 more
5 terms
restricted stock units financial
"The restricted stock units (the "RSUs") were granted by the Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2023 Stock Incentive Plan financial
"were granted by the Issuer pursuant to its 2023 Stock Incentive Plan"
Non-Employee Director Compensation Program financial
"as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program"
Stock Option financial
"The option to purchase shares of the Issuer's common stock (the "Stock Option")"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"will vest in full (100%) on the first anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Adrian Adams receive from Akebia Therapeutics (AKBA)?
Adrian Adams received 35,700 restricted stock units and a stock option for 53,600 shares. Both awards were granted as part of director compensation and are tied to Akebia’s 2023 Stock Incentive Plan.
What is the exercise price of Adrian Adams’ new Akebia (AKBA) stock option?
The new stock option for Adrian Adams has an exercise price of $1.02 per share. It covers 53,600 shares of Akebia common stock and was granted under the company’s 2023 Stock Incentive Plan.
When do Adrian Adams’ Akebia (AKBA) restricted stock units vest?
The 35,700 restricted stock units granted to Adrian Adams vest 100% on the first anniversary of the grant date. They can also vest earlier, immediately before the first annual stockholder meeting after the grant, if that occurs sooner.
When do Adrian Adams’ new Akebia (AKBA) stock options become exercisable?
The 53,600-share stock option becomes fully exercisable on the first anniversary of the grant date. It may vest earlier immediately before the first annual stockholder meeting after the grant, provided Adrian Adams maintains continuous service.
What plan governs Adrian Adams’ new Akebia (AKBA) equity awards?
Both the restricted stock units and the stock option were granted under Akebia’s 2023 Stock Incentive Plan. The terms also follow the Fifth Amended and Restated Non-Employee Director Compensation Program for board members.
AI-generated analysis. How Rhea-AI works. Not financial advice.
